Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mehta, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 311 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vangani, V; Drage, J; Mehta, J; Mathew, AK; Duhamel, J
      Maleated ethylene-propylene random copolymers: Determination of the microstructure and association level by fluorescence spectroscopy

      JOURNAL OF PHYSICAL CHEMISTRY B
    2. Sirohi, B; Powles, R; Mehta, J; Treleaven, J; Raje, N; Kulkarni, S; Rudin, C; Bhagwati, N; Horton, C; Saso, R; Singhal, S; Parikh, P
      The implication of compromised renal function at presentation in myeloma -Similar outcome in Patients who receive high-dose therapy: A single-centerstudy of 251 previously untreated patients

      MEDICAL ONCOLOGY
    3. Singhal, S; Mehta, J
      Thalidomide in cancer - Potential uses and limitations

      BIODRUGS
    4. Heffernan, MP; Do, JH; Mehta, J
      Antinuclear antibodies in dermatology

      SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
    5. Quilitz, RE; Arnold, AD; Briones, GR; Dix, SP; Ippoliti, C; Kennedy, LD; Lucich, JL; Mehta, J; Peters, BG; Tice, DS
      Practice guidelines for lipid-based amphotericin B in stem cell transplantrecipients

      ANNALS OF PHARMACOTHERAPY
    6. Kern, JK; Miller, VS; Cauller, L; Kendall, R; Mehta, J; Dodd, M
      Effectiveness of N,N-dimethylglycine in autism and pervasive developmentaldisorder

      JOURNAL OF CHILD NEUROLOGY
    7. Safdar, A; van Rhee, F; Henslee-Downey, JP; Singhal, S; Mehta, J
      Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxison incidence and outcome

      BONE MARROW TRANSPLANTATION
    8. Mehta, J; Oyama, Y; Winter, J; Williams, S; Tallman, M; Singhal, S; Villa, M; Shook, T; Burt, R; Traynor, A; Soff, G; Masarik, S; Ramsey, G; Gordon, L
      CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit

      BONE MARROW TRANSPLANTATION
    9. Nabhan, C; Mehta, J; Tallman, MS
      The role of bone marrow transplantation in acute promyelocytic leukemia

      BONE MARROW TRANSPLANTATION
    10. Sirohi, B; Powles, R; Kulkarni, S; Rudin, C; Saso, R; Lal, R; Singhal, S; Mehta, J; Horton, C; Treleaven, J
      Comparison of new patients with Bence-Jones, IgG and IgA myeloma receivingsequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

      BONE MARROW TRANSPLANTATION
    11. Chiang, KY; Van Rhee, F; Godder, K; Bridges, K; Adams, S; Mehta, J; Henslee-Downey, PJ
      Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    12. Singhal, S; Powles, R; Mehta, J
      Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.

      NEW ENGLAND JOURNAL OF MEDICINE
    13. Sirohi, B; Powles, R; Kulkarni, S; Rudin, C; Saso, R; Rigg, A; Horton, C; Singhal, S; Mehta, J; Treleaven, J
      Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myeloma

      BRITISH JOURNAL OF CANCER
    14. Badros, A; Barlogie, B; Morris, C; Desikan, R; Martin, SR; Munshi, N; Zangari, M; Mehta, J; Toor, A; CottlerFox, M; Fassas, A; Aniassie, E; Schichman, S; Tricot, G
      High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions (vol 97, pg 2574, 2001)

      BLOOD
    15. Singhal, S; Powles, R; Treleaven, J; Kulkarni, S; Sirohi, B; Horton, C; Millar, B; Shepherd, V; Tait, D; Saso, R; Rowland, A; Long, S; Mehta, J
      A low CD34(+) cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34(+) cells/kg be considered the minimum threshold?

      BONE MARROW TRANSPLANTATION
    16. Singhal, S; Safdar, A; Chiang, KY; Godder, K; van Rhee, F; Garner, F; Foster, B; Dubovsky, D; Henslee-Downey, PJ; Mehta, J
      Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosis

      BONE MARROW TRANSPLANTATION
    17. Powles, R; Sirohi, B; Kulkarni, S; Bhagwati, N; Saso, R; Raje, N; Horton, C; Singhal, S; Mehta, J; Treleaven, J
      Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients

      BONE MARROW TRANSPLANTATION
    18. Desikan, KR; Tricot, G; Dhodapkar, M; Fassas, A; Siegel, D; Vesole, DH; Jagannath, S; Singhal, S; Mehta, J; Spoon, D; Anaissie, E; Barlogie, B; Munshi, N
      Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone

      BONE MARROW TRANSPLANTATION
    19. Singhal, S; Powles, R; Kulkarni, S; Treleaven, J; Sirohi, B; Millar, B; Shepherd, V; Saso, R; Rowland, A; Long, S; Cabral, S; Horton, C; Mehta, J
      Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    20. Sirohi, B; Powles, R; Treleaven, J; Mainwaring, P; Kulkarni, S; Pandha, H; Bhagwati, N; Horton, C; Singhal, S; Mehta, J
      The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

      BONE MARROW TRANSPLANTATION
    21. Kulkarni, S; Powles, R; Treleaven, J; Singhal, S; Horton, C; Sirohi, B; Bhagawati, N; Tait, D; Saso, R; Killick, S; Pinkerton, R; Atra, A; Meller, S; Mehta, J
      Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

      BONE MARROW TRANSPLANTATION
    22. Powles, R; Mehta, J; Kulkarni, S; Treleaven, J; Millar, B; Marsden, J; Shepherd, V; Rowland, A; Sirohi, B; Tait, D; Horton, C; Long, S; Singhal, S
      Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

      LANCET
    23. Mehta, J; Venkatraman, S
      Poverty statistics: Barmecide's feast

      ECONOMIC AND POLITICAL WEEKLY
    24. Erzurum, V; Obermeyer, R; Smaroff, G; Mehta, J
      Soft-tissue images. Melanosis coli

      CANADIAN JOURNAL OF SURGERY
    25. Saso, R; Kulkarni, S; Mitchell, P; Treleaven, J; Swansbury, GJ; Mehta, J; Powles, R; Ashley, S; Kuan, A; Powles, T
      Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

      BRITISH JOURNAL OF CANCER
    26. Kulkarni, S; Powles, R; Treleaven, J; Riley, U; Singhal, S; Horton, C; Sirohi, B; Bhagwati, N; Meller, S; Saso, R; Mehta, J
      Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants

      BLOOD
    27. Siegel, DS; Lim, SH; Tricot, G; Desikan, KR; Fassas, A; Mehta, J; Singhal, S; Anaissie, E; Jagannath, S; Barlogie, B
      Stem cell transplantation for multiple myeloma - 10 years later

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    28. Mehta, JL; Li, DY; Mehta, J
      Use of antioxidants in cardiovascular medicine

      ANTIOXIDANTS AND CARDIOVASCULAR DISEASE
    29. Mehta, J
      The graft-versus-myeloma effect

      ALLOGENEIC IMMUNOTHERAPY FOR MALIGNANT DISEASES
    30. Mehta, J; Powles, R; Treleaven, J; Swansbury, GJ; Kulkarni, S; Saso, R; Min, T; Singhal, S
      The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy

      LEUKEMIA & LYMPHOMA
    31. Singhal, S; Powles, R; Treleaven, J; Kulkarni, S; Horton, C; Mehta, J
      Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling

      LEUKEMIA & LYMPHOMA
    32. Singhal, S; Powles, R; Kulkarni, S; Treleaven, J; Saso, R; Mehta, J
      Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse

      LEUKEMIA & LYMPHOMA
    33. Mehta, J
      Business excellence through quality: Indian experience

      TOTAL QUALITY MANAGEMENT
    34. Aslan, T; Fassas, AT; Desikan, R; Siegel, D; Munshi, NC; Mehta, J; Singhal, S; Barlogie, B; Anaissie, E
      Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy

      BONE MARROW TRANSPLANTATION
    35. Singhal, S; Mehta, J; Desikan, K; Siegel, D; Singh, J; Munshi, N; Spoon, D; Anaissie, E; Ayers, D; Barlogie, B
      Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy

      BONE MARROW TRANSPLANTATION
    36. Singhal, S; Powles, R; Treleaven, J; Kulkarni, S; Horton, C; Mehta, J
      Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation

      BONE MARROW TRANSPLANTATION
    37. Kulkarni, S; Rodriguez, M; Lafuente, A; Mateos, P; Mehta, J; Singhal, S; Saso, R; Dait, D; Treleaven, JG; Powles, RL
      Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

      BONE MARROW TRANSPLANTATION
    38. Singhal, S; Mehta, J
      Reimmunization after blood or marrow stem cell transplantation

      BONE MARROW TRANSPLANTATION
    39. Kulkarni, S; Powles, RL; Treleaven, JG; Singhal, S; Saso, R; Horton, C; Killick, S; Tait, D; Ramiah, V; Mehta, J
      Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

      BONE MARROW TRANSPLANTATION
    40. Singhal, S; Mehta, J; Desikan, R; Ayers, D; Roberson, P; Eddlemon, P; Munshi, N; Anaissie, E; Wilson, C; Dhodapkar, M; Zeldis, J; Barlogie, B; Siegel, D; Crowley, J
      Antitumor activity of thalidomide in refractory multiple myeloma.

      NEW ENGLAND JOURNAL OF MEDICINE
    41. Mehta, J; Li, DY; Mehta, JL
      Vitamins C and E prolong time to arterial thrombosis in rats

      JOURNAL OF NUTRITION
    42. Sirohi, B; Powles, R; Mehta, J; Raje, N; Kulkarni, S; Ramiah, V; Saso, R; Horton, C; Bhagwati, N; Singhal, S; Treleaven, J
      Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system

      BRITISH JOURNAL OF HAEMATOLOGY
    43. Desikan, R; Dhodapkar, M; Siegel, D; Fassas, A; Singh, J; Singhal, S; Mehta, J; Vesole, D; Tricot, G; Jagannath, S; Anaissie, E; Barlogie, B; Munshi, NC
      High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    44. Mehta, J
      Lipid preparations of amphotericin for the treatment of fungal infections

      BRITISH JOURNAL OF HAEMATOLOGY
    45. Siegel, DS; Desikan, KR; Mehta, J; Singhal, S; Fassas, A; Munshi, N; Anaissie, E; Naucke, S; Ayers, D; Spoon, D; Vesole, D; Tricot, G; Barlogie, B
      Age is not a prognostic variable with autotransplants for multiple myeloma

      BLOOD
    46. Barlogie, B; Jagannath, S; Desikan, KR; Mattox, S; Vesole, D; Siegel, D; Tricot, G; Munshi, N; Fassas, A; Singhal, S; Mehta, J; Anaissie, E; Dhodapkar, D; Naucke, S; Cromer, J; Sawyer, J; Epstein, J; Spoon, D; Ayers, D; Cheson, B; Crowley, J
      Total therapy with tandem transplants for newly diagnosed multiple myeloma

      BLOOD
    47. DESIKAN KR; BARLOGIE B; JAGANNATH S; VESOLE DH; SIEGEL D; FASSAS A; MUNSHI N; SINGHAL S; MEHTA J; TINDLE S; NELSON J; BRACY D; MATTOX S; TRICOT G
      COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA

      Journal of clinical oncology
    48. MEHTA J; SINGHAL S
      GRAFT-VERSUS-MYELOMA

      Bone marrow transplantation
    49. ZOMAS A; SASO R; POWLES R; MACKAY H; SINGHAL S; TRELEAVEN J; MEHTA J
      RED-CELL FRAGMENTATION (SCHISTOCYTOSIS) AFTER BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    50. BARLOGIE B; TRICOT G; DESIKAN KR; SIEGEL D; MEHTA J; SINGHAL S; JAGANNATH S
      DOUBLE AUTOTRANSPLANTS (DAT) FOR 542 PATIENTS WITH MULTIPLE-MYELOMA (MM)

      Bone marrow transplantation
    51. MEHTA J; TRICOT G; JAGANNATH S; AYERS D; SINGHAL S; SIEGEL D; DESIKAN K; MUNSHI N; FASSAS A; MATTOX S; VESOLE D; CROWLEY J; BARLOGIE B
      SALVAGE AUTOLOGOUS OR ALLOGENEIC TRANSPLANTATION FOR MULTIPLE-MYELOMAREFRACTORY TO OR RELAPSING AFTER A FIRST-LINE AUTOGRAFT

      Bone marrow transplantation
    52. ZOMAS A; STEFANOUDAKI K; FISFIS M; PAPADAKI T; MEHTA J
      GRAFT-VERSUS-MYELOMA AFTER DONOR LEUKOCYTE INFUSION - MAINTENANCE OF MARROW REMISSION BUT EXTRAMEDULLARY RELAPSE WITH PLASMACYTOMAS

      Bone marrow transplantation
    53. MEHTA J; POWLES R; TRELEAVEN T; KULKARNI S; HORTON C; TAIT D; SINGHAL S
      LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER ALLOGRAFTING FOR ACUTE-LEUKEMIA

      Bone marrow transplantation
    54. SASO R; KULKARNI S; KILLICK S; REGE K; MEHTA J; SWANSBURY J; MATUTES E; ATRA A; MORILLA R; POWLES R; TRELEAVEN J; CATOVSKY D
      IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES IN PATIENTS WITH MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-M0)

      Bone marrow transplantation
    55. SASO R; KULKARNI S; KILLICK S; REGE K; MEHTA J; SWANSBURY J; MATUTES E; ATRA A; MORILLA R; POWLES R; TRELEAVEN J; CATOVSKY D
      THERAPY OF ACUTE MEGAKARYOCYTIC LEUKEMIA (AML-M7)

      Bone marrow transplantation
    56. TRELEAVEN J; POWLES R; SINGHAL S; KULKARNI S; TAIT D; HORTON C; MEHTA J
      LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER AUTOGRAFTING FOR ACUTE-LEUKEMIA

      Bone marrow transplantation
    57. MEHTA J; POWLES R; TRELEAVEN J; KULKARNI S; SINGHAL S
      PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN ACUTE MYELOID-LEUKEMIA - IS RELAPSE THE ONLY EVENTUAL OUTCOME

      Bone marrow transplantation
    58. KULKARNI S; POWLES R; TRELEAVEN J; SINGHAL S; MEHTA J; SASO R; HORTON C
      FACTORS AFFECTING BLOOD COMPONENT REQUIREMENT AFTER AUTOGRAFT FOR HEMATOLOGICAL MALIGNANCIES

      Bone marrow transplantation
    59. POWLES R; KULKARNI S; MEHTA J; TRELEAVEN J; MILLAR B; SHEPHERD V; TAIT D; ANTRUM J; NEVILLE F; LONG S; ROWLAND A; SHAW K; SINGHAL S
      A DOUBLE-BLIND RANDOMIZED STUDY COMPARING THE EFFICACY OF ALLOGENEIC MARROW VERSUS BLOOD STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    60. KULKARNI S; POWLES R; SINGHAL S; MEHTA J; TRELEAVEN J; SHAW K; LONG S; ROWLAND A
      FEASIBILITY OF DONATING BOTH MARROW AND BLOOD-CELLS WITHIN A WEEK IN NORMAL DONORS

      Bone marrow transplantation
    61. SINGHAL S; POWLES R; KULKARNI S; TRELEAVEN J; SASO R; LONG S; ROWLAND A; SHAW K; MILLAR B; SHEPHERD V; CABRAL S; MEHTA J
      COMPARISON OF CELL YIELDS IN A SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF ALLOGENEIC MARROW VS BLOOD STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    62. SINGHAL S; POWLES R; KULKARNI S; TRELEAVEN J; MEHTA J
      IMMUNOTHERAPY OF ACUTE-LEUKEMIA RELAPSING AFTER ALLOGENEIC TRANSPLANTATION - THE INSEPARABILITY OF GVHD AND GRAFT-VS-LEUKEMIA, AND THE PROBLEM OF EXTRAMEDULLARY RELAPSE

      Bone marrow transplantation
    63. KULKARNI S; POWLES R; MEHTA J; SINGHAL S; HORTON C; TRELEAVEN J
      TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCIES IN PATIENTS ABOVE THE AGE OF 50 YEAR

      Bone marrow transplantation
    64. MEHTA J; POWLES R; KULKARNI S; TRELEAVEN J; SINGHAL S; CUNNINGHAM D; TAIT D; CATOVSKY D
      BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA

      Bone marrow transplantation
    65. POWLES R; CUNNINGHAM D; JAMESON B; TILEY C; MEHTA J; MILAN S; HEWITSON M
      RANDOMIZED PLACEBO-CONTROLLED EVALUATION OF PROPHYLACTIC FLUCONAZOLE AFTER BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    66. KULKARNI S; POWLES R; SINGHAL S; TRELEAVEN J; HORTON C; MELLER S; PINKERTON CR; ATRA A; TAIT D; MEHTA J
      2ND CANCERS AND NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS

      Bone marrow transplantation
    67. KULKARNI S; POWLES R; TRELEAVEN J; SINGHAL S; RAJE N; RAMIAH V; GREGORY K; DARK G; MILLAR B; SHEPHERD V; NEVILLE F; ANTRUM J; HORTON C; MILAN S; MEHTA J
      COMPARISON OF EQUAL DOSES OF LENOGRASTIM AND FILGRASTIM FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Bone marrow transplantation
    68. POWLES R; CUNNINGHAM D; GORE M; KULKARNI S; RAMIAH V; MEHTA J
      LONG-TERM FOLLOW-UP OF MYELOMA PATIENTS TREATED WITH 140 MG M-2 MELPHALAN WITHOUT AUTOLOGOUS TRANSPLANTATION/

      Bone marrow transplantation
    69. SUMPTER K; POWLES R; RAJE N; KULKARNI S; RAMIAH V; HILL M; HORTON C; MILAN S; MEHTA J; SINGHAL S; TRELEAVEN J
      A SINGLE INSTITUTION REVIEW OF CASES OF AL AMYLOIDOSIS

      Bone marrow transplantation
    70. LAFUENTE A; MATEOS P; RODRIGUEZ M; KULKARNI S; MEHTA J; SINGHAL S; SASO R; GREGORY K; DARK G; TRELEAVEN J; POWLES R
      HEPATIC VENO-OCCLUSSIVE (VOD) TREATED WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA)

      Bone marrow transplantation
    71. BAZZINO O; AYLWARD P; HAINS A; SLANY J; STEINBACH K; VANDEWERF F; VRINTS C; COELHO O; RAMIRES J; BOGATY P; BOUDREAULT J; DIODATI J; GOSSARD D; KOUZ S; LARAMEE P; LEMAY M; MAILLETTE S; THEROUX P; BOTERO R; ARCE M; HEIKKILA J; DANCHIN D; WEBER S; KROMER EP; NEUMANN FJ; NIENABER C; KATRITSIS D; PAPAZAGLOU N; BENHORIN J; DAVID D; TZIVONI D; GUAZZI M; MOGUEL R; VERDEJO J; BONNIER J; DEZWAAN C; HAMER AW; WHITE HD; AARONES M; ARVESEN K; FOSSUM E; HENESTAM B; ROLLAG A; RIBEIRO V; COMMERFORD P; LANDLESS P; MARX J; WEICH H; ANCILLO P; CATURLA J; CIVEIRA E; FERRERO J; FIGUERAS J; GINESTAL R; RUANO M; ERHARDT L; SYLVEN C; LUSCHER T; MOCCETTI T; ADAMS P; ADGEY AAJ; BULLER N; CANEPA R; FURNISS S; GREENBAUM R; HALL J; JENNINGS K; KOONER J; LEVY R; LIPKIN D; NOBLE M; ROTHMAN M; ABRAHAMSON D; AGUIRRE F; AMBROSE J; ANDERSON HV; ANDERSON J; ARORA R; BABB J; BHASIN S; BITTAR N; BOTTI R; BOWLES M; BROWN A; COHEN M; COLFER H; DALEY W; DAWLEY D; DETRANO R; EISENBERG P; FARHAT N; FAXON D; FREY M; FRIEDMAN S; GOLDSCHLAGER N; GRADMAN A; GUTIERREZ F; HATTEMER C; HERRMANN H; HOCHMAN J; ISRAEL N; KIERNAN J; KOREN M; KRAMER J; LING F; MEHTA J; MODY F; MOHIUDDIN S; NAFZIGER A; NAIR R; NIEDERMAN A; PALABRICA T; RODRIGUEZ S; ROSENSON R; RUTHERFORD J; SCHMEDTJE J; SHAH PK; SHARMA S; SMITH S; SMITHERMAN T; STILLABOWER M; TIERSTEIN P; VAUGHAN D; WATERS D; WEINSTOCK P; WILLIAMS M; YAKUBOV S; ZOBLE R; KLEIMAN NS; LIPSCHUTZ KH; SAX FL; CAIRNS J; ESPELAND M; FITZGERALD G; VERSTRAETE M; WEAVER WD; WILLIAMS DO; DREIFUS LS; NASMITH J; RUNGE M; GROSSMAN W; SNAPINN SM; BREMER M; FRAME V; HUTNYAN J; LAPPE JT; SERGIO M; THORNTON A
      A COMPARISON OF ASPIRIN PLUS TIROFIBAN WITH ASPIRIN PLUS HEPARIN FOR UNSTABLE ANGINA

      The New England journal of medicine
    72. DHODAPKAR MV; SINGH J; MEHTA J; FASSAS A; DESIKAN KR; PERLMAN M; MUNSHI NC; BARLOGIE B
      ANTI-MYELOMA ACTIVITY OF PAMIDRONATE IN-VIVO

      British Journal of Haematology
    73. KULKARNI S; POWLES R; SINGHAL S; MEHTA J; TRELEAVEN J; HORTON C; MELLER S; PINKERTON CR; ATRA A; TAIT D
      2ND CANCERS AFTER NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

      British Journal of Haematology
    74. KULKARNI S; POWLES R; TRELEAVEN J; SINGHAL S; MEHTA J; SASO R; HORTON C
      FACTORS AFFECTING BLOOD COMPONENT REQUIREMENT AFTER AUTOGRAFT FOR HEMATOLOGICAL MALIGNANCIES

      British Journal of Haematology
    75. KULKARNI S; POWLES R; MEHTA J; SINGHAL S; HORTON C; TRELEAVEN J
      TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCIES IN PATIENTS ABOVE THE AGE OF 50 YEAR

      British Journal of Haematology
    76. DELORD C; POWLES R; MEHTA J; WILSON K; TRELEAVEN J; MELLER S; CATOVSKY D
      FAMILIAL ACUTE MYELOID-LEUKEMIA - 4 MALE MEMBERS OF A SINGLE-FAMILY OVER 3 CONSECUTIVE GENERATIONS EXHIBITING ANTICIPATION

      British Journal of Haematology
    77. SAWYER JR; LUKACS JL; MUNSHI N; DESIKAN KR; SINGHAL S; MEHTA J; SIEGEL D; SHAUGHNESSY J; BARLOGIE B
      IDENTIFICATION OF NEW NONRANDOM TRANSLOCATIONS IN MULTIPLE-MYELOMA WITH MULTICOLOR SPECTRAL KARYOTYPING

      Blood
    78. POWLES R; SINGHAL S; TRELEAVEN J; KULKARNI S; HORTON C; MEHTA J
      IDENTIFICATION OF PATIENTS WHO MAY BENEFIT FROM PROPHYLACTIC IMMUNOTHERAPY AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA ON THE BASIS OF LYMPHOCYTE RECOVERY EARLY AFTER TRANSPLANTATION

      Blood
    79. SASO R; ZOMAS A; HAMBLIN M; DUNLOP L; SWANSBURY GJ; MIN T; SINGHAL S; POWLES R; TRELEAVEN J; MEHTA J
      SEQUENTIAL DEVELOPMENT OF MYELODYSPLASIA AND ACUTE MYELOID-LEUKEMIA BUT WITH NO KARYOTYPIC EVOLUTION AFTER AUTOGRAFTING IN A PATIENT WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    80. MEHTA J; POWLES R; SINGHAL S; RILEY U; TRELEAVEN J; CATOVSKY D
      ANTIMICROBIAL PROPHYLAXIS TO PREVENT OPPORTUNISTIC INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA AFTER ALLOGENIC BLOOD OR MARROWTRANSPLANTATION

      Leukemia & lymphoma
    81. MEHTA J; POWLES R; TRELEAVEN J; HORTON C; SHEPHERD V; HALE G; WALDMANN H; SINGHAL S
      AUTOLOGOUS TRANSPLANTATION WITH CD52 MONOCLONAL ANTIBODY-PURGED MARROW FOR ACUTE LYMPHOBLASTIC-LEUKEMIA - LONG-TERM FOLLOW-UP

      Leukemia & lymphoma
    82. HJIYIANNAKIS P; MEHTA J; MILAN S; POWLES R; HINSON J; TAIT D
      MELPHALAN, SINGLE-FRACTION TOTAL-BODY IRRADIATION AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA - REVIEW OF TRANSPLANT-RELATED MORTALITY

      Leukemia & lymphoma
    83. SINGHAL S; POWLES R; TRELEAVEN J; RATTENBURY H; MEHTA J
      PILOCARPINE HYDROCHLORIDE FOR SYMPTOMATIC RELIEF OF XEROSTOMIA DUE TOCHRONIC GRAFT-VERSUS-HOST DISEASE OR TOTAL-BODY IRRADIATION AFTER BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

      Leukemia & lymphoma
    84. SINGHAL S; POWLES R; TRELEAVEN J; HORTON C; MEHTA J
      LONG-TERM SAFETY OF GM-CSF (MOLGRAMOSTIM) ADMINISTRATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES - 5-YEARFOLLOW-UP OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY

      Leukemia & lymphoma
    85. SINGHAL S; POWLES R; TRELEAVEN J; HORTON C; PINKERTON CR; MELLER S; MEHTA J
      CYTOMEGALOVIREMIA AFTER AUTOGRAFTING FOR LEUKEMIA - CLINICAL-SIGNIFICANCE AND LACK OF EFFECT ON ENGRAFTMENT

      Leukemia
    86. MEHTA J; POWLES R; TRELEAVEN J; MILLAR B; PROCTOR H; CABRAL S; SHEPHERD V; SINGHAL S
      PROSPECTIVE, CONCURRENT COMPARISON OF THE COBE SPECTRA AND HEMONETICSMCS-3P CELL SEPARATORS FOR LEUKAPHERESIS AFTER HIGH-DOSE FILGRASTIM IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Journal of clinical apheresis
    87. LYONS B; MEHTA J
      CONTRACTS, OPPORTUNISM AND TRUST - SELF-INTEREST AND SOCIAL ORIENTATION

      Cambridge journal of economics
    88. FRANKLIN IM; MEHTA J; ROOT T
      THE USE OF AMPHOTERICIN-B LIPID COMPLEX

      Journal of antimicrobial chemotherapy
    89. POWLES R; RAJE N; MILAN S; MILLAR B; SHEPHERD V; MEHTA J; SINGHAL S; KULKARNI S; VINER C; GORE M; CUNNINGHAM D; TRELEAVEN J
      OUTCOME ASSESSMENT OF A POPULATION-BASED GROUP OF 195 UNSELECTED MYELOMA PATIENTS UNDER 70 YEARS OF AGE OFFERED INTENSIVE TREATMENT

      Bone marrow transplantation
    90. MEHTA J; TRICOT G; JAGANNATH S; DESIKAN KR; SIEGEL D; SINGHAL S; MUNSHI N; VESOLE D; MATTOX S; BRACY D; BARLOGIE B
      HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT

      Bone marrow transplantation
    91. MEHTA J; POWLES R; KULKARNI S; TRELEAVEN J; SINGHAL S
      INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY OF LEUKEMIA RELAPSING AFTER ALLOGENEIC TRANSPLANTATION - SINGLE-CENTER EXPERIENCE OF 32 ADULT PATIENTS

      Bone marrow transplantation
    92. MEHTA J; KELSEY S; CHU P; POWLES R; HAZEL D; RILEY U; EVANS C; NEWLAND A; TRELEAVEN J; SINGHAL S
      AMPHOTERICIN-B LIPID COMPLEX (ABLC) FOR THE TREATMENT OF CONFIRMED ORPRESUMED FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Bone marrow transplantation
    93. MEHTA J; POWLES R; TRELEAVEN J; HORTON C; MELLER S; PINKERTON CR; SINGHAL S
      OUTCOME OF ACUTE-LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION- UTILITY OF 2ND TRANSPLANTS AND ADOPTIVE IMMUNOTHERAPY

      Bone marrow transplantation
    94. MEHTA J; POWLES R; SINGHAL S; HORTON C; MIDDLETON G; EISEN T; MELLER S; PINKERTON CR; TRELEAVEN J
      EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS

      Bone marrow transplantation
    95. SINGHAL S; POWLES R; TRELEAVEN J; MEHTA J
      SENSITIVITY OF SECONDARY ACUTE MYELOID-LEUKEMIA RELAPSING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION TO IMMUNOTHERAPY WITH INTERFERON-ALPHA-2B

      Bone marrow transplantation
    96. MEHTA J
      DO VARIATIONS IN MOLECULAR-STRUCTURE AFFECT THE CLINICAL EFFICACY ANDSAFETY OF LIPID-BASED AMPHOTERICIN-B PREPARATIONS

      Leukemia research
    97. RAJE N; POWLES R; KULKARNI S; MILAN S; MIDDLETON G; SINGHAL S; MEHTA J; MILLAR B; VINER C; RAYMOND J; TRELEAVEN J; CUNNINGHAM D; GORE M
      A COMPARISON OF VINCRISTINE AND DOXORUBICIN INFUSIONAL CHEMOTHERAPY WITH METHYLPREDNISOLONE (VAMP) WITH THE ADDITION OF WEEKLY CYCLOPHOSPHAMIDE (C-VAMP) AS INDUCTION TREATMENT FOLLOWED BY AUTOGRAFTING IN PREVIOUSLY UNTREATED MYELOMA

      British Journal of Haematology
    98. HIORNS LR; SWANSBURY GJ; MEHTA J; MIN T; DAINTON MG; TRELEAVEN J; POWLES RL; CATOVSKY D
      ADDITIONAL CHROMOSOME-ABNORMALITIES CONFER WORSE PROGNOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA

      British Journal of Haematology
    99. RAJE N; POWLES R; HORTON C; MILLAR B; SHEPHERD V; MIDDLETON G; KULKARNI S; EISEN T; MEHTA J; SINGHAL S; TRELEAVEN J
      COMPARISON OF MARROW VS BLOOD-DERIVED STEM-CELLS FOR AUTOGRAFTING IN PREVIOUSLY UNTREATED MULTIPLE-MYELOMA

      British Journal of Cancer
    100. MEHTA J; POWLES R; TRELEAVEN J; KULKARNI S; HORTON C; SINGHAL S
      NUMBER OF NUCLEATED CELLS INFUSED DURING ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN IMPORTANT MODIFIABLE FACTOR INFLUENCINGOUTCOME

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:13:45